Insider Transactions in Q2 2022 at Chemo Centryx, Inc. (CCXI)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2022
|
Jennifer Lyn Herron Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,237
+50.0%
|
-
|
|
Jun 09
2022
|
James L Tyree Director |
SELL
Open market or private sale
|
Direct |
3,863
-8.42%
|
$96,575
$25.93 P/Share
|
|
May 26
2022
|
Thomas A. Edwards Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,723
+9.89%
|
-
|
|
May 20
2022
|
Rita Jain EVP, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,726
+17.72%
|
-
|
|
May 20
2022
|
Henry A Mckinnell Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,726
+9.6%
|
-
|
|
May 20
2022
|
Geoffrey M. Parker Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
7,726
+26.82%
|
-
|
|
May 20
2022
|
James L Tyree Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,726
+25.14%
|
-
|
|
May 02
2022
|
Geoffrey M. Parker Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+9.13%
|
$175,000
$14.42 P/Share
|